The role of NT-proBNP as a prognostic marker in pulmonary hypertension. - Suppr | 超能文献

The role of NT-proBNP as a prognostic marker in pulmonary hypertension.

作者信息

Souza Rogério, Jardim Carlos, Carvalho Carlos, Rubenfeld Gordon

出版信息

Chest. 2006 Nov;130(5):1627; author reply 1627-8. doi: 10.1378/chest.130.5.1627.

DOI:10.1378/chest.130.5.1627

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The role of NT-proBNP as a prognostic marker in pulmonary hypertension.

Chest. 2006 Nov;130(5):1627; author reply 1627-8. doi: 10.1378/chest.130.5.1627.

2

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.血清N末端脑钠肽作为肺动脉高压患者的预后参数。

Chest. 2006 May;129(5):1313-21. doi: 10.1378/chest.129.5.1313.

3

The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.运动诱导的氨基末端脑利钠肽前体反应与未经治疗的肺动脉高压患者疾病严重程度的相关性：一项队列研究。

Respir Res. 2018 Jan 15;19(1):8. doi: 10.1186/s12931-017-0712-9.

4

B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.B型利钠肽作为儿童肺动脉高压的一个参数：一项系统评价

Eur J Pediatr. 2015 Oct;174(10):1267-75. doi: 10.1007/s00431-015-2619-0. Epub 2015 Aug 23.

5

Role of Pro-Brain Natriuretic Peptide Serum Concentration in the Detection of Pulmonary Hypertension in Patients With End-Stage Lung Diseases Referred for Lung Transplantation.脑钠肽前体血清浓度在接受肺移植评估的终末期肺病患者肺动脉高压检测中的作用

Transplant Proc. 2018 Sep;50(7):2044-2047. doi: 10.1016/j.transproceed.2018.02.149. Epub 2018 Mar 14.

6

Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.比较脑利钠肽（BNP）和 N 端脑利钠肽前体（NT-proBNP）在系统性硬化症患者肺动脉高压筛查中的应用。

J Rheumatol. 2010 Oct;37(10):2064-70. doi: 10.3899/jrheum.090997. Epub 2010 Jul 15.

7

Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.先天性肺气道发育不良中的利钠肽：系统评价。

J Perinatol. 2020 Apr;40(4):607-615. doi: 10.1038/s41372-019-0588-2. Epub 2020 Jan 10.

8

C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.C反应蛋白和N末端脑钠肽前体作为戈谢病肺动脉高压的替代标志物。

Blood Cells Mol Dis. 2005 May-Jun;34(3):201-5. doi: 10.1016/j.bcmd.2005.01.002.

9

MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.MR-proADM 预测运动能力和生存率优于 PH 的其他生物标志物。

Lung. 2015 Dec;193(6):901-10. doi: 10.1007/s00408-015-9802-y. Epub 2015 Sep 12.

10

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.不对称二甲基精氨酸单独及联合N末端B型利钠肽前体作为系统性硬化症相关肺动脉高压筛查生物标志物的作用：一项病例对照研究

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):129-136. Epub 2016 May 23.

引用本文的文献

1

Biomarkers and prognostic indicators in pulmonary arterial hypertension.肺动脉高压中的生物标志物和预后指标

Curr Hypertens Rep. 2015 Jun;17(6):556. doi: 10.1007/s11906-015-0556-y.

2

Quality of life as a prognostic marker in pulmonary arterial hypertension.生活质量作为肺动脉高压的一项预后指标

Health Qual Life Outcomes. 2014 Aug 30;12:130. doi: 10.1186/s12955-014-0130-3.